CRBP intrinsic value
Corbus Pharmaceuticals earnings report beats estimated earnings per share by 666.67%, but misses revenue by Infinity%
Corbus Pharmaceuticals reported earnings per share of $0. 03 on revenue of $null, the consensus between analysts was $-0.17 per share on revenue of $10M.
Corbus Pharmaceuticals (CRBP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.